Onsdag 10 September | 10:41:51 Europe / Stockholm

Prenumeration

2025-09-09 13:13:00

Redeye return with a research update following BioArctic's Q2 and latest newsflow. We largely reiterate our view of the company but note a strong positive trend in the share price lately, in light of some positive news and increased interest in the share.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/